ScripArtificial intelligence-enabled drug discovery and development is one of the hottest topics in the biopharmaceutical industry, capturing the imaginations of investors, entrepreneurs and veterans alike
In VivoRiding high on the wave of its dual GIP/GLP-1 agonist, tirzepatide, Eli Lilly awarded its CEO the highest total remuneration package of the top 12 big pharma companies in 2024. David Ricks’s total com
ScripThere were fireworks ahead of the 4th of July festivities over the pharma sector as analysts weighed in on the rumors that a multi-billion dollar deal is in the offing between AstraZeneca and Summit T
ScripData from the Phase III GENEr8-1 trial testing BioMarin’s Roctavian in patients with severe hemophilia A over a period of five years showed that the gene therapy maintained durable bleed control and s